ISSN 1006-298X      CN 32-1425/R

Chinese Journal of Nephrology, Dialysis & Transplantation ›› 2024, Vol. 33 ›› Issue (3): 269-274.DOI: 10.3969/j.issn.1006-298X.2024.03.014

Previous Articles     Next Articles

Advances in pathogenesis,diagnosis and treatment of hepatorenal syndrome related acute kidney injury

  

  • Online:2024-06-28 Published:2024-06-26

Abstract: Hepatorenal syndrome (HRS) is a type of cirrhosis-related renal damage with a unique pathophysiological mechanism. HRS-AKI is the subtype that needs special attention. In addition to the classical mechanisms of hemodynamic disorders,the occurrence of HRS-AKI also involves a variety of pathophysiological mechanisms such as intestinal bacterial translocation,systemic inflammation,renal microcirculation disorders and cirrhotic cardiomyopathy and so on. Early diagnosis and treatment can improve the poor prognosis of HRS-AKI. Albumin plus terlipressin is a widely recommended first-line treatment,nevertheless liver transplantation is the only definitive treatment for HRS. This article reviews the new definition,diagnostic and grading criteria,pathogenesis,and treatment of HRS-AKI.


Key words: advanced cirrhosis, hepatorenal syndrome, acute kidney injury, human albumin, terlipressin